Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Total Non-Current Liabilities: 2023-2024

Historic Total Non-Current Liabilities for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $658,000.

  • Zhengye Biotechnology Holding's Total Non-Current Liabilities was N/A to $649,788 in Q2 2025 from the same period last year, while for Jun 2025 it was $649,788, marking a year-over-year change of. This contributed to the annual value of $658,000 for FY2024, which is 55.21% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Total Non-Current Liabilities stood at $658,000 for FY2024, which was down 55.21% from $1.5 million recorded in FY2023.
  • In the past 5 years, Zhengye Biotechnology Holding's Total Non-Current Liabilities registered a high of $1.5 million during FY2023, and its lowest value of $658,000 during FY2024.
  • For the 2-year period, Zhengye Biotechnology Holding's Total Non-Current Liabilities averaged around $1.1 million, with its median value being $1.1 million (2023).
  • Data for Zhengye Biotechnology Holding's Total Non-Current Liabilities shows a maximum YoY crashed of 55.21% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zhengye Biotechnology Holding's Total Non-Current Liabilities stood at $1.5 million in 2023, then plummeted by 55.21% to $658,000 in 2024.